Thymine

Thymine

SCHEMBL750450

Cc1c[nH]c(=O)[nH]c1=O.Cc1c[nH]c(=O)[nH]c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATAD2 Q6PL18 1/20 1.00
DPYD Q12882 4/20 0.52
MAPT P10636 3/20 0.52
GAA P10253 3/20 0.52
ALDH1A1 P00352 2/20 0.52
LMNA P02545 1/20 0.52
CYP19A1 P11511 1/20 0.52
TSHR P16473 1/20 0.52
THPO P40225 1/20 0.52
MTOR P42345 1/20 0.52
HTT P42858 1/20 0.52
HBB P68871 1/20 0.52
PMP22 Q01453 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
KDM4C Q9H3R0 1/20 0.41
POLB P06746 1/20 0.40
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thymine SCHEMBL5235 1.00
Thymine SCHEMBL15323914 1.00 ATAD2 (1.00) ATAD2DPYDMAPTGAAALDH1A1
Thymine SCHEMBL29669526 1.00
Thymine SCHEMBL17201833 1.00 ATAD2 (1.00) ATAD2DPYDMAPTGAAALDH1A1
Thymine SCHEMBL2724033 0.97 ATAD2 (0.95) ATAD2DPYDMAPTGAAALDH1A1
Thymine SCHEMBL8649294 0.97 ATAD2 (0.95) ATAD2DPYDMAPTGAAALDH1A1
Thymine SCHEMBL5176783 0.97 ATAD2 (0.95) ATAD2DPYDMAPTGAAALDH1A1
Thymine SCHEMBL935833 0.97 ATAD2 (0.95) ATAD2DPYDMAPTGAAALDH1A1
Thymine SCHEMBL31403209 0.97 ATAD2 (0.95) ATAD2DPYDMAPTGAAALDH1A1
Thymine SCHEMBL4811815 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119442163-A DNA fine tuning language model primitive mining method based on long-short-term memory network 宁波数字孪生(东方理工)研究院 2025-02-14 CN claimed
EP-3523742-A1 A RISK STRATIFICATION METHOD FOR A PATIENT HAVING A POLYMORPHISM Helicalhelp LLC (US) 2019-08-14 EP claimed
WO-2018067897-A1 A RISK STRATIFICATION METHOD FOR A PATIENT HAVING A POLYMORPHISM HelicalHelp LLC (US) 2018-04-12 WO claimed
EP-1756317-A4 METHODS FOR IDENTIFYING RISK OF OSTEOARTHRITIS AND TREATMENTS THEREOF SEQUENOM INC (US) 2008-05-28 EP claimed
EP-1756317-A2 METHODS FOR IDENTIFYING RISK OF OSTEOARTHRITIS AND TREATMENTS THEREOF SEQUENOM, INC. (US) 2007-02-28 EP claimed
WO-2005100604-A2 METHODS FOR IDENTIFYING RISK OF OSTEOARTHRITIS AND TREATMENTS THEREOF SEQUENOM, INC. (US) 2005-10-27 WO claimed
EP-4587116-A2 METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES MarvelBiome, Inc. (US) 2025-07-23 EP disclosed
CN-119442163-A DNA fine tuning language model primitive mining method based on long-short-term memory network 宁波数字孪生(东方理工)研究院 2025-02-14 CN disclosed
WO-2024058984-A2 METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES MarvelBiome, Inc. (US) 2024-03-21 WO disclosed
CN-112646771-B Cell line of human follicle cumulus cells or/and granulosa cells and preparation method thereof 艾尔斯(浙江)医学科技有限公司 2023-04-14 CN disclosed
CN-115340478-A Schiff base ligand and preparation method and application of polynuclear rare earth complex thereof 温州医科大学 2022-11-15 CN disclosed
WO-2021113938-A1 VITAMIN AND MINERAL FOOD SUPPLEMENT CELLAVIT REPRESENTAÇÃO DE PRODUTOS NATURAIS LTDA (BR) 2021-06-17 WO disclosed
CN-112646771-A Cell line of human follicle cumulus cells or/and granulosa cells and preparation method thereof 艾尔斯(浙江)医学科技有限公司 2021-04-13 CN disclosed
EP-1543019-A2 MODIFIED PNA MOLECULES Santaris Pharma A/S (DK) 2005-06-22 EP disclosed
WO-2004024757-A2 MODIFIED PNA MOLECULES SANTARIS PHARMA A/S (DK) 2004-03-25 WO disclosed
US-6333315-B1 FOR THERAPY OF AIDS(ACQUIRE IMMUNODEFICIENCY SYNDROME) YAMASA CORPORATION (JP) 2001-12-25 US disclosed
US-5591722-A ANTICANCER AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1997-01-07 US disclosed
EP-0491793-A4 2'-DEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AND ANTICANCER AGENTS 1993-03-03 EP disclosed
EP-0491793-A1 2'-DEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AND ANTICANCER AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1992-07-01 EP disclosed
WO-1991004033-A1 2'-DEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AND ANTICANCER AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1991-04-04 WO disclosed